Clinical Trials in Chicago

Showing 7301-7320 of 15,574 trials

Marketability of a Technology-based Intervention to Increase HPV Vaccination

NCT03497936

The overall goal of this SBIR Phase II project is to reduce cancer rates by marketing a brief, easily implemented technology-based intervention that increases human papillomavirus (HPV) vaccination among Planned Parenthood and other clients. The intervention's innovative technology allows for the investigators' narrative videos to be presented along will reminder texts. It will be evaluated for use in waiting rooms and promises to overcome vaccination barriers among high risk but underserved low SES and minority populations.

Human Papilloma Virus

Real Prevention, LLC360 participantsStarted May 2018

Irvine, California, United States • Chicago, Illinois, United States • St Louis, Missouri, United States +4 more locations

COMPLETEDPhase 32.2 miles

Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

NCT03372161

This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment. The purpose of the study is to measure how well a single injection of the experimental medication, SP-102, relieves pain. The study will also investigate the side effects of SP-102.

Lumbosacral Radicular Pain

Scilex Pharmaceuticals, Inc.401 participantsStarted Dec 2017

Mobile, Alabama, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +34 more locations

Marketability of a Technology-based Intervention to Increase HPV Vaccination

Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

Find Trials by Condition in Chicago

A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection